Oracle JD Edwards EnterpriseOne Tools up to 9.2.8.2 Web Runtime SEC improper authorization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.3 | $0-$5k | 0.00 |
Summary
A vulnerability has been found in Oracle JD Edwards EnterpriseOne Tools and classified as critical. Affected by this issue is some unknown functionality of the component Web Runtime SEC. The manipulation leads to improper authorization. This vulnerability is traded as CVE-2025-21509. It is possible to initiate the attack remotely. There is no exploit available. The affected component should be upgraded.
Details
A vulnerability, which was classified as critical, has been found in Oracle JD Edwards EnterpriseOne Tools. This issue affects an unknown part of the component Web Runtime SEC. The manipulation with an unknown input leads to a improper authorization vulnerability. Using CWE to declare the problem leads to CWE-285. The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action. Impacted is availability. The summary by CVE is:
Vulnerability in the JD Edwards EnterpriseOne Tools product of Oracle JD Edwards (component: Web Runtime SEC). Supported versions that are affected are Prior to 9.2.9.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise JD Edwards EnterpriseOne Tools. Successful attacks of this vulnerability can result in unauthorized ability to cause a hang or frequently repeatable crash (complete DOS) of JD Edwards EnterpriseOne Tools. CVSS 3.1 Base Score 6.5 (Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H).
It is possible to read the advisory at oracle.com. The identification of this vulnerability is CVE-2025-21509 since 12/25/2024. The exploitation is known to be easy. The attack may be initiated remotely. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $0-$5k at the moment (estimation calculated on 03/18/2025). The attack technique deployed by this issue is T1548.002 according to MITRE ATT&CK.
Upgrading to version 9.2.9.0 eliminates this vulnerability.
Be aware that VulDB is the high quality source for vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.5VulDB Meta Temp Score: 6.3
VulDB Base Score: 6.5
VulDB Temp Score: 6.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 6.5
CNA Vector (oracle): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Improper authorizationCWE: CWE-285 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: JD Edwards EnterpriseOne Tools 9.2.9.0
Timeline
12/25/2024 🔍01/21/2025 🔍
01/21/2025 🔍
03/18/2025 🔍
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2025-21509 (🔍)
GCVE (CVE): GCVE-0-2025-21509
GCVE (VulDB): GCVE-100-292799
Entry
Created: 01/21/2025 22:36Updated: 03/18/2025 03:39
Changes: 01/21/2025 22:36 (65), 03/18/2025 03:39 (1)
Complete: 🔍
Cache ID: 216::103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.